Related Experiment Videos
Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack
Devin L Brown1, Lynda D Lisabeth, Canopy Roychoudhury
1University of Michigan, Ann Arbor, MI 48109, USA. devinb@umich.edu
Stroke
|May 10, 2005
Summary
Patients who experience a stroke or transient ischemic attack (TIA) face a higher risk of a subsequent stroke than a cardiac event. This finding is crucial for planning effective preventive therapies to reduce recurrent ischemic events.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Patients with ischemic stroke and transient ischemic attack (TIA) are susceptible to recurrent cerebrovascular and cardiac events.
- Identifying the more probable recurrent event aids in planning preventive therapies.
Purpose of the Study:
- To compare the incidence of recurrent cardiac events versus recurrent stroke in patients with a history of ischemic stroke or TIA.
- To inform prophylactic therapy selection based on the likelihood of recurrent events.
Main Methods:
- A cohort of 1923 patients with ischemic stroke/TIA was identified from Michigan Medicare claims (2001-2001).
- Outcomes including cardiac events (MI, PTCA, CABG) and ischemic strokes were tracked from 2001 to 2003.
- Cumulative incidence estimates were used to compare the occurrence of cardiac events versus stroke as secondary events.
Main Results:
- Over the follow-up period, 239 patients experienced a stroke as their first recurrent event, while 172 had a cardiac event.
- The cumulative incidence of stroke at 2 years was 11.8%, compared to 7.7% for cardiac events.
- Myocardial infarction (MI) was the most common cardiac event, accounting for 62.8% of all cardiac events.
Conclusions:
- The risk of experiencing a recurrent stroke after an initial stroke or TIA is higher than the risk of a cardiac event.
- This suggests a greater propensity for recurrent ischemic events to manifest in the brain rather than the heart following an initial stroke/TIA.
- These findings have significant implications for the selection of prophylactic therapies in post-stroke/TIA patients.